https://padlet.com/apnmalaysia2022/21j3q41hjoc3d911 If you have any questions related to E-posters, please post your questions at the respective Poster ID en-us 2022-11-08 05:19:13 UTC 2022-11-14 08:53:49 UTC hello@padlet.com https://padlet.com/apnmalaysia2022/21j3q41hjoc3d911/wish/2374419998 2022-11-08 05:44:56 UTC https://padlet.com/apnmalaysia2022/21j3q41hjoc3d911/wish/2374419998 apnmalaysia2022 https://padlet.com/apnmalaysia2022/21j3q41hjoc3d911/wish/2378083492 I would like to ask, which step in the model development did you incorporate the machine learning. could you please briefly explain. thank you 

]]> 2022-11-10 06:01:53 UTC https://padlet.com/apnmalaysia2022/21j3q41hjoc3d911/wish/2378083492 apnmalaysia2022 https://padlet.com/apnmalaysia2022/21j3q41hjoc3d911/wish/2378102297 in summary, what is the role of UGT2B7 in VPA's PK?

]]> 2022-11-10 06:22:12 UTC https://padlet.com/apnmalaysia2022/21j3q41hjoc3d911/wish/2378102297 apnmalaysia2022 https://padlet.com/apnmalaysia2022/21j3q41hjoc3d911/wish/2378104832 i would like to ask, to use machine learning and incorporating it with pharmacometrics, what is the minumum number of subjects / data we need to use for model development, training and testing?]]> 2022-11-10 06:25:00 UTC https://padlet.com/apnmalaysia2022/21j3q41hjoc3d911/wish/2378104832 https://padlet.com/apnmalaysia2022/21j3q41hjoc3d911/wish/2378111535 I would like to ask, did you try to compare the model performance if you use Time to event (parametric) approach to predict the event (CA)]]> 2022-11-10 06:31:37 UTC https://padlet.com/apnmalaysia2022/21j3q41hjoc3d911/wish/2378111535 https://padlet.com/apnmalaysia2022/21j3q41hjoc3d911/wish/2378139974 Do you have any comment on the first figure with green line shown in your poster?]]> 2022-11-10 06:57:06 UTC https://padlet.com/apnmalaysia2022/21j3q41hjoc3d911/wish/2378139974